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interveinIn spite of our conceptual view of how differential gene expression is used to deﬁne different cell identities,
we still do not understand how different cell identities are translated into actual cell properties. The example
discussed here is that of the ﬂy wing, which is composed of twomain cell types: vein and intervein cells. These
two cell types differ in many features, including their adhesive properties. One of the major differences is that
intervein cells express integrins, which are required for the attachment of the two wing layers to each other,
whereas vein cells are devoid of integrin expression. The major signaling pathways that divide the wing to
vein and intervein domains have been characterized. However, the genetic programs that execute these two
alternative differentiation programs are still very roughly drawn. Here we identify the bHLH protein Delilah
(Dei) as amediator between signaling pathways that specify intervein cell-fate and one of themost signiﬁcant
realizators of this fate, βPS integrin. Dei's expression is restricted to intervein territories where it acts as a
potent activator of βPS integrin expression. In the absence of normal Dei activity the level of βPS integrin is
reduced, leading to a failure of adhesion between the dorsal and ventral wing layers and a consequent
formation of wing blisters. The effect of Dei on βPS expression is not restricted to the wing, suggesting that Dei
functions as a general genetic switch, which is turned on wherever a sticky cell-identity is determined and
integrin-based adhesion is required.ppaport Faculty of Medicine,
4 8295225.
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
The differentiation of many cell types and tissues requires
remodeling of cells' adhesive properties. Proper adhesive interactions
between neighboring cells, and between cells to the extracellular
matrix, are important for tissue morphogenesis and maintenance of
tissue integrity. In addition, cell adhesion molecules often function as
cell surface receptors important for the communication between cells
and their environment. The transduction of extracellular signals via
cell-adhesion receptor molecules, such as integrins, can affect cell
proliferation, survival, differentiation, migration and many other
aspect of cell biology (Bokel and Brown, 2002; Dupuy and Caron,
2008; Harburger and Calderwood, 2009; Hynes, 2002; Perkins et al.,
2010; Streuli, 2009; Vicente-Manzanares et al., 2009; Zaidel-Bar et al.,
2007). Thus, the genetic program of almost any developmental
process should include tight temporal and spatial regulation on the
expression of cell adhesion molecules. Very little is known about the
regulatory processes that specify adhesive properties of cells.
Through our studies on chordotonal organ development, we
became interested in the bHLH protein Delilah (Dei). Dei is expressed
during embryonic development almost exclusively in specialized cellsthat provide anchoring sites to either muscles (tendon cells), or
proprioceptors (chordotonal attachment cells) (Armand et al., 1994;
Inbal et al., 2004). This unique pattern of expression may indicate that
Dei plays an important role in a basic developmental program that is
common to different types of attachment cells. It is reasonable to
assume that Dei, being a putative bHLH transcription factor, is not
involved directly in adhesion processes that characterize such cells.
Rather, it may regulate the expression of subordinate genes that are
required to confer attachment cells with their unique adhesive
properties. The only other cells that express Dei in the embryo are
fusion-competent myoblasts, prior to their fusion to founder cells
(Artero et al., 2003). It is possible that Dei regulates in these cells the
expression of cell surface molecules that are required for their
interactions with other cells, similarly to its hypothesized role in
chordotonal organs and tendon cells.
The developmental roles of Dei and its possible involvement in the
regulation of cell adhesion and attachment have not been investigated
so far. To test our hypotheses about the involvement of Dei in the
differentiation of ‘sticky’ cell types, we took advantage of a relatively
simple system, the ﬂy wing. The wing offers an excellent model
system to investigate the molecular mechanisms that regulate the
differentiation of cells with different adhesive properties. The wing
blade consists of two epithelial sheets that adhere tightly to each
other in the intervein regions through integrin-based basal junctions
(Fristrom et al., 1993). Five longitudinal and two transverse veins
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interveins differ from each other in cell size, shape, cuticle
pigmentation, trichome orientation and the repertoire of cell
adhesion molecules that they express. For example, βPS integrin is
expressed in intervein cells only, whereas laminin A and collagen are
expressed only in vein cells (Fristrom et al., 1993).
The Drosophila wing starts to develop in the embryo, when 20–30
cells form the embryonic wing imaginal disc. Further proliferation and
differentiation of thewingdisc takeplaceduring larval andpupal stages.
Patterning of the wing disc is initiated at larval stages when broad
provein and intervein regions are established by the activity of the
Hedgehog and Dpp pathways (Bier, 2000; Sturtevant et al., 1993)
(reviewed in Blair, 2007; De Celis, 2003). Subsequently, the EGFR and
Notch pathways are activatedwithin the provein domain, subdividing it
into a prospective vein region, where EGFR signaling is active, and two
adjacent rows of boundary cells, where the Notch signaling acts to
prevent vein differentiation (for reviews see Blair, 2007;DeCelis, 2003).
The intervein cells are characterized at the same time by the expression
of the Drosophila serum response factor—Blistered (Bs) (Fristrom et al.,
1994;Montagneet al., 1996; Rochet al., 1998) and the bHLHproteinNet
(Brentrup et al., 2000). The vein–intervein choice remains plastic for
quite some time and it depends on both vein-speciﬁc and intervein-
speciﬁc genes (reviewed in Blair, 2007). For example, antagonistic
interactions betweenBs and the EGFRpathway are required tomaintain
the identities of interveins versus veins, respectively (Fristrom et al.,
1994; Roch et al., 1998; Sturtevant and Bier, 1995).
Following larval stages, thewing disc everts and the twowing layers
go through two distinct phases of adhesion to form the wing blade. The
dorsal and ventral wing epithelia initially appose during the prepupal
period, separate at early pupal stages, and then re-appose 21–36 h after
pupariation (AP) (Brabant et al., 1996; Fristrom et al., 1994). Proteins of
the Integrin family play cardinal roles in these processes (Brabant et al.,
1996; Dominguez-Gimenez et al., 2007; Fristrom et al., 1993). Even
though the main pathways that deﬁne the initial development of vein
versus intervein territories are well established (reviewed in Blair,
2007), very little is known about later events responsible for the
realization of the distinct properties of vein versus intervein cells.
In this work we show that dei plays an important role in wing
development where it provides an important missing link between
the master regulatory networks of gene expression that divide the
wing to veins and interveins and the actual morphogenesis and
terminal differentiation of intervein cells.
Dei is expressed in the developing interveins starting at early
prepupal stages. Its expression is regulated by the main signaling
pathways, which divide the wing to vein versus intervein territories.
Phenotypic analyses of deimutant alleles suggest that Dei plays a dual
role in wing development. In early prepupal stages it is required to
prevent ectopic vein development and promote intervein develop-
ment. Later on it is required for terminal differentiation and proper
adhesion of intervein cells. Finally, we demonstrate that Dei exerts its
effects on wing development by means of speciﬁcally regulating the
expression of βPS integrin. βPS integrin is expressed in both wing
layers and is required for the formation of active integrin dimers with
bothαPS1, in the dorsalwing layer, andαPS2 at the ventralwing layer.
Thus, by regulating the expression βPS alone, Dei affects integrin-
mediated signaling and cell adhesion. The effects of Dei onβPS integrin
expression are not restricted to the wing, suggesting that Dei acts as a
general regulator of βPS expression, thus constituting an important
part in the mechanism that generates sticky cells in Drosophila.
Materials and methods
Fly strains
To identify point mutations in the dei gene we used the FlyTill
service (http://tilling.fhcrc.org:9366/ﬂy/) to screen 2500 mutantstrains (half of the Zucker collection) for point mutations in a 1500-
bp fragment, spanning the entire coding sequence of the gene.
Three strains that harbor a point mutation in dei and exhibit extra-
vein phenotypes when crossed to Df(3R)ED6232 were identiﬁed:
dei3 (G294E, Zucker stock Z3-PMM-0233), dei8 (S233N, Zucker stock
Z3-5654) and dei14 (S243L, Zucker stock Z3-0313). Other mutant
strains used in this study were: deie01478 and deiMB3174 (FlyBase,
1999) (obtained from the exelixis collection at Harvard and
H. Bellen, respectively), tx1 (Collins, 1928), Ax16172 (Kelley et al.,
1987), bs12 and bs14 (Fristrom et al., 1994), and Df(3R)ED6232
(FlyBase, 1999). The following Gal4 drivers and UAS strains were
used: P{GD4329}v37630 and P{y{+t7.7} v{+t1.8}=TRiP.JF01995}
attP2 (UAS-dei-IR); P{KK108584}v100606 (UAS-CG5447-IR);
P{KK107140}v100218 and P{GD11656}v47331 (UAS-Hex-t2-IR);
P{GD11655}v46573 and P{GD11655}v46574 (UAS-Hex-t1-IR) (Dietzl
et al., 2007; Perkins et al., 2009; FlyBase, 1999); UAS-DN-DER
(O'Keefe et al., 1997), UAS-dei (a gift of T. Volk), UAS-dei-attP2 (this
work); UAS-VP16-Dei (this work), UAS-Da (Hinz et al., 1994), 1.65-
Gal4 (Sotillos and de Celis, 2006), en-Gal4, MS1096-Gal4, 24B-Gal4
(FlyBase, 1999). To generate act-Gal4 expressing clones in pupae we
crossed yw, hsFLP; Sp/Cy; actNCD2NGal4, UAS-GFP Y+ ﬂies to either
UAS-dei or UAS-dei-IR and heat-shocked 2nd instar larvae 1 h at
37 °C.
DNA constructs
To generate the UAS-VP16-dei construct the full-length dei coding
sequence was ampliﬁed by PCR from dei cDNA clone and was cloned
into the XhoI–XbaI sites of the pUAST vector, in frame and downstream
of the VP16 activation domain (as described in Inbal et al., 2001).
Immunohistochemistry and in situ hybridization
Staining of whole-mount embryos was performed using standard
techniques. In situ hybridization to embryos was performed as
described in Robinow et al. (1997).
Whole-mount in situ hybridization and immunostaining of pupal
wings were carried out as described by Sturtevant and Bier (http://
www-bier.ucsd.edu/imagdisc.html). Brieﬂy, pupae were aged at 24°
or 29 °C. The pupal case was removed and the head and tip of the
abdomen were cut off. Internal tissues were washed away with PBS
using a small syringe. Pupaewere then ﬁxed in 4% formaldehyde over-
night at 4 °C (for in situ) or 1 h at room temperature (for
immunostaining). Following several washes in PBT (PBS, 0.1%
Tween 20), the wing cuticle was peeled using delicate forceps.
Staining was performed as for embryos, except that incubation with
antibodies was performed in PBT plus 5% normal goat serum, and the
washeswere longer (30 min each). Stained embryos and pupal tissues
were viewed using bright ﬁeld and confocal microscopy (Axioskop,
Zeiss and LSM510, Zeiss, respectively). Fluorescence intensity was
measured from confocal images using ImageJ (NIH, USA). Average
values and standard deviations were calculated and Student's t-test
analysis was carried out.
Probes and antibodies
A dei-speciﬁc probe was made by amplifying a 400-bp fragment
from a cDNA template, using the following primers: 5′ GACAAAA-
GAGGGGCTCCAA 3′ and 5′ CTCCCGATTCGCACTCTC 3′. A mys-speciﬁc
probe was made by amplifying a 545-bp fragment from exon 6, using
the following primers: 5′ TGGACACAGACGATCCAC AT 3′ and 5′
GTACCATGACCGGAGCAGAT 3′. A mew-speciﬁc probe was prepared
by amplifying a 563-bp fragment, which is included in both theA and B
transcripts of the gene, using the following primers: 5′ TCATC-
CATTGGCCATACTCA 3′ and 5′ TTCCACCCGAGGATACTCAC 3′. An
if-speciﬁc probe, which recognizes four transcript variants of the
Fig. 1. dei is expressed in intervein domains of pre-pupal and pupal wings. (A–C) In situ
hybridization with a dei-speciﬁc probe to larval, pre-pupal and pupal yw wings. (A) A
wing disc of a 3rd instar larva; dei-speciﬁc mRNA is not evident. (B) A prepupal wing,
2-h APF; deimRNA is observed in intervein territories (asterisks) and is excluded from
developing veins (arrows). (C) A pupal wing 35-h APF; dei is expressed in the entire
intervein domain. (D) Anti-Dei staining of a 35-h APF wing. Higher levels of Dei protein
accumulate in the vein/intervein border (arrow) and in sensory organs along the wing
margin (arrowhead). (E) A close-up view of a 35-h APF wing hybridized to a dei probe.
The arrow points to the vein/intervein border, where higher levels of dei mRNA
accumulate. (F) A close-up view of a 35-h APF wing ﬂuorescently stained with anti-Dei
antibodies. Sensory organs along the wing margin accumulate high levels of Dei
(arrow).
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cDNA as a template, with the following primers: 5′ CCATGCATGC-
TACTGACCAC 3′ and 5′ ATGTAGAAGGCAGCCTCGAA 3′. All PCR
productswere cloned into the pGEM-T-easy vector (Promega,Madison,
WI, USA) and used as templates to synthesize anti-sense and sense
digoxigenin labeled RNA probes.
Anti-Dei serum was raised in rabbits against a GST-Dei fusion
protein (SIGMA, Israel) and was afﬁnity-puriﬁed on a column bearing
the ﬁrst 100 amino acids of the Dei protein. The afﬁnity-puriﬁed
antibodies were used in a 1:50 dilution.
Other primary antibodies used in this study: rat anti-Dei (1:200;
Yarnitzky et al., 1997); guinea pig anti-Stripe (1:300; Becker et al.,
1997); mouse anti-DSRF (1:100, Active Motif, Carlsbad, CA, USA);
mouse anti-βPS integrin (CF.6G11, 1:100), mouse anti-αPS1 integrin
(DK.1A4, 1:100), mouse anti-αPS2 integrin (CF.2C7, 1:100) and
mouse MAb21A6 (1:10) were obtained from the Developmental
Studies Hybridoma Bank at the University of Iowa. Secondary
antibodies for ﬂuorescent staining were Cy3, Cy2 or Cy5-conjugated
anti mouse/rabbit/rat/guinea pig (Jackson Laboratories, Bar-Harbor,
Maine, USA). Secondary antibodies for non-ﬂuorescent staining were
biotinylated anti-mouse/rabbit detected with Vecta-Stain Elite ABC-
HRP kit (Vector Laboratories, Burlingame, CA, USA).Fig. 2. dei's expression is regulated by signaling pathways dividing the wing to vein
versus intervein domains. (A, C, E) Cuticle preparations of adult wings. (B, D, F) In situ
hybridization with a dei-speciﬁc probe to 30–35-h APF wings. (A–B)Wings carrying the
gain of function Notch allele Ax16172. (C–D) Wings expressing a dominant-negative
form of DER under the regulation ofMS1096-Gal4. (B, D) dei's expression expanded into
the vein-to-intervein transformed region (arrows). (E–F) bs12 homozygous wings.
Intervein domains are partially transformed into vein tissue and the level of deimRNA is
lower than normal (F).Cuticle preparations
Anesthetized ﬂies were boiled in 10% NaOH solution for 10 min,
squeezed against the tube wall and washed in water. Wings were
dissected, and mounted in Hoyer's medium. Alternatively, ﬂies were
stored in isopropanol at 4 °C and wings were mounted in Canada
balsam (SIGMA-ALDRICH, St. Louis, MO, USA). To compare the
severity of ectopic vein phenotypes of different genotypes, wing
cuticles were prepared and photographed. The length of ectopic veins
was measured using Adobe Photoshop.Results
Dei is expressed in the intervein domains of prepupal and pupal wings
The expression pattern of Dei in the developing wing has not been
described previously. We therefore characterized the expression
pattern of dei in larval and pupal wing discs by in situ hybridization
and immunostaining. dei's expression was not detected in wing discs
of third instar larvae or immediately after pupariation (AP) (Fig. 1A
and data not shown). In wing discs dissected approximately 2 h AP
dei-speciﬁc mRNA was observed in the forming wing blade in a
spatially restricted pattern, which probably corresponds to certain
intervein territories (Fig. 1B). No expression was detected in the
dorso-ventral wing margin or in the hinge region. At 18-h AP the
expression of dei expanded to the entire prospective intervein
domain, in both the dorsal and ventral wing layers (data not
shown). dei's expression remained restricted to the intervein domain
and was excluded from the forming veins in pupal wings dissected
30–35-h AP (Fig. 1C–D). The Dei mRNA and protein accumulated at
somewhat higher levels in the vein/intervein border cells that are
deﬁned by the activity of Notch (Fig. 1D–E). The Dei protein also
accumulated at high levels in cells of sensory organs of the anterior
wing margin (Fig. 1F).
The wing disc is divided to provein and intervein zones in the 3rd
larval wing disc, prior to the onset of dei's expression. The main
pathways responsible for specifying provein domains are EGFR and
Notch. The EGFR pathway is active in the prospective vein region,
promoting vein differentiation, whereas Notch acts in the vein–
intervein boundaries, delimiting vein differentiation (Blair, 2007;
De Celis, 2003; de Celis et al., 1997; Sturtevant et al., 1993). We
hypothesized that dei's expression is normally turned on in cells that
have been already determined to differentiate as intervein cells, and
that its expression in these cells is essential for their proper
differentiation. If this is correct, then dei's expression should be
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as vein-repressing signals such as Notch and Bs.
To establish whether dei's expression is affected by the EGFR and
Notch pathways, we examined the distribution of dei's mRNA in pupal
wings with abnormal activity of these pathways. The gain-of-function
allele of Notch, Ax16172, suppresses the competence to form veins in
several regions of the wing, where intervein domains are established
instead (Fig. 2A) (de Celis et al., 1997; Kelley et al., 1987). In
accordance with our hypothesis, dei's expression expanded into theFig. 3. deimutant alleles. (A) Schematic representation of the dei locus and the identiﬁed m
intron (thin black line). The ORF (green box) is contained within the second exon. The ligh
shows the various domains of the Dei protein and the position of the point mutations. (B–C)
channels are shown in (B″, C″). (B–B″) A normal wing. (C–C″) A tx1 homozygous wing. Note t
at the anterior wingmargin that continue to express Dei in the tx1mutant. (D–E) Lateral view
(red) andMAb21A6 (blue, marks the scolopale cells of chordotonal organs). The cap (c), liga
(D–D′). In deie01478 homozygous embryos, Dei's expression is lost from tendon cells and the
situ hybridization with a dei-speciﬁc probe to 30–35-h APF wildtype (F–F′) and homozygovein-to-intervein transformed regions of Ax16172 pupal wings
(Fig. 2B), suggesting that dei is positively regulated by Notch activity.
To test whether the EGFR pathway normally suppresses dei's
expression in the vein territory, we expressed a dominant negative
form of the EGF receptor (DERDN) throughout the developing wing
under the regulation of MS1096-Gal4. This expression leads to a
partial loss of the L3, L4 and L5 veins in adult wings. In UAS-DERDN/+;
MS1096-Gal4/+ pupal wings dei's expression expanded into the
ectopic intervein domains (Fig. 2C–D), suggesting that Dei'sutant alleles. The dei gene is comprised of two exons (black boxes) separated by a 6-kb
t grey box at the top panel marks the extension of the dei33-2 deletion. The lower panel
Wings (35-h APF) stained with anti-Dei (B, C) and anti-DSRF (B′, C′); merge of the two
he loss of Dei's expression from intervein cells. The arrowhead points to sensory organs
of three abdominal segments of stage 16 embryos stained with anti-Dei (green) anti-Sr
ment (l), ligament attachment (la) and tendon cells (t) express Dei in wildtype embryos
chordotonal attachment cells and is elevated in cap and ligament cells (E–E′). (F–G) In
us deie01478 wings (G–G′). The wings were processed in parallel.
Fig. 4. dei is required for normal wing patterning and adhesion of wing layers. (A) A wildtype wing displaying normal venation. Veins L2, L3, L4 and L5 are indicated, (B) A deie01478
wing displaying the typical phenotype of creased lengthwise (arrow) pointed wing. (C) A deie01478 ﬂy displaying a typical wing blister (arrow) and held out wings. (D) A tx1mutant
wing displaying the typical crease (arrow) and extra bristle phenotype (arrowheads and inset). (E) A homozygous dei33-2 ﬂy with typical wing blisters and held out wings. (F) A dei8/
Df(3R)ED6232 wing displaying ectopic vein (arrow). (G) A dei14/Df(3R)ED6232 wing displaying ectopic cross-vein (arrow) and ectopic bristles (arrowheads and inset). (H) An
en-Gal4/+; UAS-dei-IR/+ (P{GD4329}v37630) ﬂy with blisters in the posterior region of its wings. (I) A 24B-Gal4/P{GD4329}v37630 ﬂy exhibiting held out, pointed and blistered
wings. (J) A wing of 1.65-Gal4/UAS-dei ﬂy. Loss of vein properties is evident in L4 and posterior cross-vein (arrowheads).
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EGFR pathway.
To establish whether dei's expression is regulated by the intervein-
determining gene bs, the distribution of dei's mRNA was examined in
wings homozygous for the viable allele bs12. The intervein territory of
these mutants was shown to harbor partial vein tissue identity
(Fristrom et al., 1994) and, in agreement with that, a reduction in the
level of dei's expression was observed in bs12 homozygous wings as
compared to control wings processed in parallel (Fig. 2E–F and data
not shown).
Altogether, these results suggest that the pattern of dei expression
in the wing is an accurate readout of the signaling pathways that
divide the wing to zones of vein and intervein identities, where Dei's
expression is on in cells deﬁned as intervein cells and off in vein cells.
Generation and characterization of dei LOF alleles
As a ﬁrst step towards functional analysis of the dei gene we have
isolated and characterized a series of loss-of-function (LOF) dei alleles,
which included point mutations, insertions and deletion alleles. The
different alleles used for this work are described shortly below.
The deie01478 allele (FlyBase, 1999) harbors a piggyBac intronic
insertion 1006 bp upstream to the initiation codon (Fig. 3A); the
deiMB3174 allele (Bellen et al., 2004) harbors a Minos insertion 267 bp
upstream to the coding exon (Fig. 3A); three EMS-induced hypomor-
phic alleles dei3, dei8 and dei14 were identiﬁed by TILLING (see
Materials and methods) and they all harbor point mutations that lead
to amino acid substitutions (Fig. 3A). A null allele of dei, dei33-2, was
generated by imprecise excision of the MB3174 Minos element as
described in Metaxakis et al. (2005). This allele carries a 2.7-kb
fragment of the Minos element (inserted 267 bp upstream to the
coding exon) combined with a 6.86-kb deletion that removes the
entire coding sequence of dei and two neighboring genes, hex-t1,
hex-t2 as well as part of cg5447 (Fig. 3A).
The very prominent wing phenotypes of some of the dei alleles
(described below), combined with the fact that the dei locus can be
readily mutated, made it improbable that dei mutants have not beenalready isolated and described during more than hundred years of
Drosophila research. A thorough browse through Lindsley and Zimm's
Red Book (Lindsley and Zimm, 1992) identiﬁed a prime suspect, called
taxi wings (tx), which was ﬁrstly identiﬁed in 1924 by J.L. Collins
(Collins, 1928). The beautiful drawing, the accompanying phenotypic
description of tx mutants, and the fact that tx maps to cytological
location 97 strongly suggested that tx and dei are allelic. A series of
complementation tests between the tx1 allele and several alleles of dei
suggested that dei is indeed allelic to tx. Molecular analysis of the tx1
allele did not reveal any alterations in the coding sequence of dei.
However, immunostaining of tx1 pupal wings with anti-Dei antibodies
revealed a loss of Dei's expression from intervein cells (Fig. 3B–C),
suggesting that tx1 is a regulatory allele that disrupts the normal
pattern of dei's expression.
deie01478 is also a regulatory allele that disturbs the normal
expression pattern of the dei gene. In deie01478 homozygous embryos
dei's expression was lost from all tendon cells and chordotonal
attachment cells, but was maintained (or even elevated) in the cap
and ligament cells of the chordotonal organs (Fig. 3D–E). In situ
hybridization to deie01478 homozygous pupal wings revealed a
signiﬁcant reduction in the level of dei's mRNA (Fig. 3F–G).Dei is required for proper differentiation and adhesion of intervein cells
To establish whether dei is required for terminal differentiation of
intervein cells and proper adhesion of the wing layers we character-
ized the wing phenotypes of multiple allelic combinations of dei. In
addition, we used RNA interference (RNAi) to abrogate dei's activity.
The dei mutant alleles and the RNAi caused abnormal wing
phenotypes that implicate Dei in the restriction of vein territories
and in intervein differentiation and adhesion processes. The dei alleles
fall into two phenotypic classes: mild alleles (dei3, dei8, dei14,
deiMB3174) that cause mild extra vein phenotypes, and stronger alleles
(deie01478, dei33-2, tx1) characterized by held out, arched, creased
lengthwise, smaller and pointed wings that often harbor very large
blisters ﬁlled with liquid (Fig. 4B–D). The dei14 (hemizygous over Df
Fig. 5. Dei is a positive regulator of βPS integrin expression in the wing. Wings (30–35-h APF) immunostained with anti- βPS antibodies (A, E, F, J) or co-stained for anti-Dei (blue)
and anti-βPS (red) (B–D, G–I, K–M). (A–D)Wildtype wings. (E–I) en-Gal4/UAS-deiwings show a parallel upregulation of Dei and βPS in the posterior compartment of the wing. Note
the unusual expression of βPS in vein cells (arrow in F). (J–M) en-Gal4/+; UAS-dei-IR/+ (P{GD4329}v37630) wings show a parallel reduction in the level of Dei and βPS in the
posterior compartment of the wing (39.3% and 39.2% , respectively).
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also ectopic sensory bristles on the wing (Fig. 4D, G).
The dei locus resides in a gene-rich genomic region and we know
that at least the dei33-2 allele affects three additional genes (Fig. 3A).
To verify that the observed phenotypes were caused by the reduction
in dei's activity, we used RNAi to down-regulate dei's expression in
the developing wing and tested in parallel RNAi transgenes directed
against the three neighboring genes. When double stranded RNA
(dsRNA) of dei (Dietzl et al., 2007) was produced in the posterior
compartment of the wing under the regulation of the en-Gal4 driver,
a signiﬁcant reduction of dei's mRNA and protein was observed
(Fig. 5J–K and data not shown). The wing layers of such ﬂies failed to
adhere properly and blisters were detected in the posterior wing
region in 100% of the ﬂies (n=50, Fig. 4H). When expressed under
the regulation of the 24B-Gal4 driver, which drives expression in the
proximal region of the wing blade and in ﬂight muscles (Fig. s1A), the
dsRNA of dei caused most of the observed LOF phenotypes, including
held out, pointed, arched and blistered wings as well as semilethality
at the pupal or pharate adult stage (Fig. 4I). RNAi directed against the
other three genes deleted in the dei33-2 chromosome did not cause
any of these phenotypes (Fig. s1B–E). These observations strongly
suggest that the loss of dei's activity is the cause of the observed
phenotypes. Curiously, in the RNAi crosses of all these genes we saw
occasionally a short extra-vein located in parallel, either anteriorly or
posteriorly, to L2 (Fig. s1B–E). This observation suggests that this
region in the wing is prone to develop ectopic vein tissue upon
various perturbations, complicating the analysis of dei's ectopic vein
phenotype.The blisters and extra vein phenotypes suggest that Dei is required
to promote intervein differentiation and adhesion and to prevent vein
development. To further test this hypothesis we over-expressed dei in
the wing under the regulation of the 1.65 Gal4 driver, which drives
expression mainly in the developing veins (Sotillos and de Celis,
2006). Ectopic expression of dei in the developing veins often led to
loss of vein properties and intervein-like differentiation in the L4 and
posterior cross-vein territories (Fig. 4J). This observation corroborates
the idea that Dei plays an instructive role in intervein differentiation.
Dei is a potent activator of βPS, but not αPS1 or αPS2, integrin in
intervein cells
During prepupal and pupal stages, the wing layers go through two
phases of adhesion (Brabant et al., 1996; Fristrom et al., 1994). The
βPS integrins are restricted to basal plaques in the intervein region
during the second pupal apposition (Brabant et al., 1996; Fristrom
et al., 1993). Homozygous mutant clones of myospheroid (mys, the
gene encoding for βPS integrin) lead to a failure in re-apposition of the
wing layers and the consequent formation of wing blisters (Brabant
et al., 1996), similar to the blisters seen in dei mutant ﬂies, or in ﬂies
expressing dsRNA of dei in the developingwing. In addition, weakmys
alleles, such as mysnj42, display venation defects that are very similar
to the venation defects of weak dei alleles, such as dei14 and dei8
(D'Avino and Thummel, 2000; Wilcox et al., 1989). The similar
expression pattern (Fig. 5A–D) andmutant phenotypes of dei and βPS
integrin in the wing led us to test for possible interaction between
Dei's activity and βPS expression.
Fig. 6. Dei regulates the expression of βPS, but not αPS1 or αPS2 integrin. Pupal wings, 30–35-h APF, harboring act-Gal4-expressing clones (labeled by the expression of GFP) in which the expression of either a UAS-dei or a UAS-dei-IR (P
{GD4329}v37630) transgene is induced. (A–D) Awing expressing UAS-dei-IR in GFP-labeled clones (A) stained for Dei (B, blue channel in D) and βPS (C, red channel in D). Note the parallel reduction in the level of Dei and βPS in the clones. (E)
A graph summarizing the quantiﬁcation of average ﬂuorescence intensity in GFP positive (dei-IR expressing) versus negative clones (wt tissue). An average reduction of 26% was measured for Dei, and a parallel reduction of 22.6% in the level
of βPS integrin, was measured in dei-IR expressing clones as compared to wt clones (n=17 and 19, Pb0.004 and Pb0.04, respectively). (F–I) A wing expressing UAS-dei in GFP-labeled clones (F) stained for Dei (G, blue channel in I) and βPS
(H, red channel in I). A parallel up-regulation of Dei and βPS is evident in the clones (arrow). Quantiﬁcation of the average ﬂuorescence intensity in GFP positive versus negative clones is shown in J. An average increase of 181% was measured
for Dei, and a parallel, though lower, increase of 29.8% in the level of βPS integrin, was measured in dei overexpressing clones as compared to wt clones (n=8 for each class; Pb0.0001 and P=0.031 respectively). (K–N) A wing expressing
UAS-dei in GFP-labeled clones (K) stained for Dei (L, blue channel in N) andαPS1 (M, red channel in N). Up-regulation of Dei did not lead to parallel up-regulation of αPS1 in clones (arrow). (O–R) Awing expressing UAS-dei-IR in GFP-labeled
clones (O) stained for Dei (P, blue channel in R) and αPS2 (Q, red channel in R). Down-regulation of Dei did not lead to parallel down-regulation of αPS2 in clones. (S–V) Wings stained for αPS1 (S–T) and αPS2 (U–V). (S) and (U) show
normal wings, whereas (T) and (V) show en-Gal4/UAS-dei and en-Gal4/UAS-Vp16-dei wings, respectively.
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Fig. 7. dei interacts genetically with bs and can activate βPS expression in the absence of normal Bs activity. (A–C) Wings of heterozygous bs14 (A), heterozygous dei33-2 (B) and
transheterozygous bs14/+; dei33-2/+ (C) ﬂies. Ectopic veins are indicated by arrows. The average length of extra-vein tissue is presented in the attached graph. Extra-veins were not
evident in dei33-2/+ wings, average length of 8.9 units was observed in bs14/+ ﬂies (n=56 females) whereas the average length of extra-vein tissue in transheterozygous bs14/+;
dei33-2/+ females was 14.9 units (n=60). The difference between A and C was found to be statistically signiﬁcant (P=3.93E-06). (D–F) An en-Gal4 bs12/ UAS-dei bs12 pupal wing
stained for Dei (D, blue channel in F) and βPS (E, red channel in F). Up-regulation of Dei in the posterior compartment of the bs12mutant wing leads to concomitant up-regulation of
βPS integrin.
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expression in intervein cells, we examined βPS expression in deie01478
mutant pupal wings. A signiﬁcant reduction of βPS expression was
evident (data not shown). To verify that the observed reduction in βPS
staining is not a mere reﬂection of the abnormal morphology (lack of
adhesion between wing layers) and the resulting difﬁculty to handle
deie01478 homozygous wings, we used the Gal4 system to alter the
level of dei's expression in restricted regions of the wing and
examined the effects on βPS expression.When deiwas over expressed
in the posterior compartment of the wing, dramatic enhancement of
βPS expression was evident (Fig. 5E–I). Most signiﬁcantly, βPS
expression was detected in vein cells (in L4 and L5), which normally
never express this integrin (Fig. 5F). When, in contrast, dsRNA of dei
was expressed in the posterior compartments of the wing, a
signiﬁcant reduction of βPS expression was evident (Fig. 5J–M).
Similar reduction was evident when the level of mys mRNA was
examined by in situ hybridization in wings expressing dsRNA of dei in
their posterior compartments (Fig. s2). These results demonstrate
that dei is required for activation of βPS expression in intervein cells
and is sufﬁcient to induce βPS expression when expressed ectopically
in vein cells. The effect of dei on βPS expression is cell-autonomous as
shown by clonal analysis (see below, Fig. 6).
βPS integrin is expressed in both the dorsal and ventralwing layers,
whereas the αPS subunits are expressed differentially, αPS1 in the
dorsal layer andαPS2 in the ventral layer (Brower et al., 1984;Wilcox
et al., 1981). Terminal differentiation of intervein cells relies on
accurate levels of expression of all these integrin subunits. To test
whether dei affects the expression of αPS subunits, similarly to its
effect on βPS, we generated clones that over-expressed dei and
examined them for βPS,αPS1 andαPS2 expression. All the clones that
over expressed Dei exhibited elevated levels of βPS, but such clones
did not show consistent changes in αPS1 or αPS2 expression
(Fig. 6F–N and data not shown). Similarly, unlike its effects on βPS
expression, overexpression of Dei in the posterior compartment of the
wing did not lead to upregulation ofαPS1 orαPS2 levels (Fig. 6S–V). In
addition, clones expressing dsRNA of dei consistently exhibited a
reduction in βPS expression, but no consistent changes in αPS1 or
αPS2 levels (Fig. 6A–E, O–R and data not shown). These results suggest
that Dei regulates speciﬁcally the mys gene, but does not regulate the
multiple edematouswings and inﬂated genes encoding for theαPS1 and
αPS2 subunits, respectively. This conclusion is corroborated by similar
analyses done at the mRNA level in both embryos and wings (Fig. s2).Dei functions downstream to Bs in regulating integrin expression
It was previously suggested that Bs, a major determinant of
intervein identity, acts upstream to the integrin genes in intervein
cells (Fristrom et al., 1994; Walsh and Brown, 1998). dei mutants
display wing phenotypes that resemble very much those of bs
mutants. In addition, dei interacts genetically with bs. Wings
transheterozygous for bs14 and dei33-2 exhibited more pronounced
extra-vein phenotypes than wings of ﬂies carrying bs14/+ or dei33-2/+
alone (Fig. 7A–C). This result suggests that bs and dei function in the
same genetic pathway. Based on its expression pattern, Dei is likely to
act downstream to Bs in intervein domains. To test whether dei
functions downstream to bs in regulating βPS expression, we tested
whether dei can rescue the reduced expression of βPS in bs mutants.
Over expression of dei under the regulation of en-Gal4 in homozygous
bs12 wings resulted in elevated expression of βPS in the posterior
compartment (Fig. 7D–F). This result indicates that Dei can activate
βPS expression in the absence of normal Bs activity and suggests that
dei normally acts downstream to bs in the βPS regulatory pathway.
Dei is a general regulator of βPS expression in Drosophila
The overlap between Dei's expression and βPS expression is not
restricted to the developingwing. In the embryo such co-expression is
evident in the accessory and attachment cells of the chordotonal
organs and in tendon cells (Fig. 8F–H and (Bogaert et al., 1987; Inbal
et al., 2004; Leptin et al., 1989). In the pupa, other cell types that
express high levels of Dei express also high levels of βPS integrin, for
instance the cone cells in the eye (Fig. 8A–E), where βPS is required
for anchoring rhabdomeres to the cone cell plate (Longley and Ready,
1995). We therefore tested whether the effect of Dei on βPS
expression is speciﬁc to intervein cells, or is a more general
phenomenon.
To establish whether Dei is involved in regulating βPS expression
in other pupal tissues we examined mitotic eye clones that expressed
double strand RNA of dei under the regulation of act-Gal4. As shown in
Fig. 8, cone cells with diminished Dei expression exhibited consistent
reduction in the level of βPS expression (Fig. 8A–E), indicating that dei
is involved in the regulation of integrin expression in these cells.
The ability of Dei to induce the expression of βPS in the embryo
was tested by ectopically expressing dei under the regulation of
en-GAL4. In en-Gal4/UAS-dei embryos a low, but signiﬁcant, level of
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cells (Fig. 8I–K). When an activating form of the gene, Vp16-Dei, was
expressed under the regulation of en-Gal4, a dramatic enhancement of
βPS expression was observed both at the mRNA and protein levelsFig. 8. Dei affects βPS expression in multiple tissues. (A–D) A pupal eye (35-h APF) expressin
(C, blue channel in A) and βPS (D, red channel in A). Dei is expressed in the cone cells, but n
parallel reduction in the level of βPS only in cone cells within the clones (arrows in D). (E) Qu
An average decrease of 61.3% in the intensity of anti-Dei staining, and a parallel though lo
contained within dei-IR expressing clones as compared to wt clones (n=8 for each class; Pb0
anti-Dei (red) and anti-βPS (cyan) antibodies. (F–H) A wildtype embryo. Co-localization of
organs, as well as in tendon cells (T). (I–K) An en-Gal4/UAS-dei embryo. Ectopic express
up-regulation of βPS expression (arrows in I). (L–N) An en-Gal4/UAS-VP16-dei embryo. Ectop
in the VP16-dei-expressing cells (arrow in M). (O–Q) An en-Gal4/UAS- dei, UAS-da embryo
expression in the expressing cells (arrows in P).(Figs. 8L–N and s2), indicating that Dei can activate βPS expression in
embryonic tissues. We hypothesized that the expression of Dei alone
could not strongly activate βPS expression due to a lack of its bHLH
dimerization partner. Indeed, co-expression of Dei and its putativeg UAS-dei-IR in GFP-labeled clones under the regulation of act-Gal4 (B), stained for Dei
ot in the surrounding pigment cells. Therefore the reduction in the level of Dei leads to
antiﬁcation of the average ﬂuorescence intensity in GFP positive versus negative clones.
wer decrease of 23.3% in the level of βPS integrin, was measured in individual facets
.0001 and P=0.016, respectively). (F–Q) Lateral view of stage 16 embryos stained with
Dei and βPS is evident in the cap (C) and ligament (L) cells of the lateral chordotonal
ion of Dei in epidermal stripes within the en domain (arrows in J) leads to parallel
ic expression of Vp16-Dei (arrows in N) leads to strong up-regulation of βPS expression
. Concomitant ectopic expression of Dei and Da leads to strong up-regulation of βPS
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much higher levels of βPS expression (Fig. 8O–Q). Such induction of
βPS expression was not seen upon ectopic expression of Da alone
(data not shown). These observations indicate that Dei can function as
an activator of βPS expression in the embryo and that this activity
depends on its binding to Da. Homozygous deie01478 or dei33-2 embryos
did not display consistently an obvious reduction in the levels of the
βPS protein (data not shown). This observation may indicate that Dei
is not a major regulator of integrin expression during embryogenesis.
However, due to the high level of maternal contribution of βPS we
cannot rule out the involvement of Dei in regulatingmys expression in
late stages of embryogenesis or in larval stages. In this respect, it is
worth noting that despite the overall normal morphology of muscles,
tendons and chordotonal organs in deie01478 homozygous embryos,
homozygous 3rd instar larvae are sluggish and less coordinated than
heterozygous siblings, suggesting that dei mutant animals have
impaired contractile and/or proprioceptive functions.
Discussion
Integrins, which are conserved between all metazoans, are
heterodimer receptors composed of α and β subunits. Among other
functions, integrins mediate stable adhesion between cells to the
extracellular matrix. These strong attachments are crucial for tissue
integrity and performance. In ﬂies, in the absence of members of the
integrin family, muscles detach from their tendons and blisters form
between the two wing layers (reviewed in Brown et al., 2000).
Similarly, in mammals, mutations in integrin subunits result in
different pathologies. For example, in the autosomal recessive
disorder epidermolysis bullosa, genetic defects in α6 and β4 integrin
subunits cause disruption of the mechanical link between the
basement membrane and the basal keratinocyte layers, leading to
epidermal blistering of the skin (reviewed in Wehrle-Haller and
Imhof, 2003). This disease can be also caused by reduction in integrin
concentration caused by the generation of anti-integrin auto-
antibodies. Abnormal levels of integrin expression are also associated
with tumor progression and metastasis (Guo and Giancotti, 2004).
The role of integrins as regulators of cell adhesion in Drosophila has
been extensively studied, however, we still lack a full understanding
of how integrin expression is regulated and by which transcription
factors. Here we identify the bHLH transcription factor Dei as an
important positive regulator of the expression of βPS, the major
β subunit in Drosophila.
During embryonic development Dei's expression is conﬁned
mainly to cells that adhere strongly to other cells and are able to
withstand mechanical strain, for instance, tendon cells that attach
body wall muscle to the cuticle. Moreover, when different types of
cells arise from within a uniform cell population, or through
asymmetric cell division, Dei's expression is restricted to the ‘stickier’
types of cells. For example, in the chordotonal organ lineage, Dei is
expressed in the four types of support cells (cap, ligament, cap-
attachment and ligament-attachment), but is excluded from the
neuron and glia. Similar phenomenon is seen in the developing wing
where Dei is expressed only in intervein territories, where the ventral
and dorsal layers adhere to each other, and is not expressed in vein
cells that do not adhere to cells of the opposite layer. In all these
systems, Dei does not function as a selector of cell identity, but it is
required to realize the selected fate by activating a developmental
program that speciﬁes adhesive properties of cells.
Although we have not characterized dei's expression in all
developmental stages and tissues, published data of various micro-
array analyses suggest that dei is expressed in other developmental
and physiological contexts where up-regulation of βPS integrin is
required. For example, dei was up-regulated when larvae were
exposed to immune challenge, or when mutant larvae exhibited an
increase in lamellocyte cell population (Irving et al., 2005; Kwon et al.,2008). Lamellocytes represent a subset of hemocytes in Drosophila,
which differentiate in response to speciﬁc immune challenge. The
lamellocytes aggregate around large pathogens to form a rigid
laminated capsule that conﬁnes the pathogen and enables its
elimination (for a review see Crozatier and Meister, 2007). This
encapsulation process requires members of the integrin family that
presumably mediate the lamellocyte's attachment (Irving et al.,
2005).
In this work we focused mainly on the role of dei in intervein cells
and showed that dei provides a missing link between the genetic
speciﬁcation of these epithelial cells and their differentiation. Our data
place dei downstream to the major signaling pathways that divide the
wing to regions of veins and interveins and downstream to Bs, which
works as a selector of intervein identity. It remains to be determined
whether dei is a direct target of Bs, and whether it is a direct regulator
of βPS, however the results of the rescue experiment suggest that the
effect of Bs on integrin expression is mediated, at least in part, by the
activity of Dei.
The venation phenotypes caused by weak dei alleles could be also
attributed to the effects of Dei on βPS expression. Even though vein
and intervein territories are established during early stages of wing
development, the decision remains plastic for at least 24-h APF
(reviewed in Blair, 2007). Maintenance of the right fates depends on
both vein-speciﬁc and intervein-speciﬁc genes. Appropriate levels of
integrin expression are required for the maintenance of intervein fate,
as suggested by the ectopic vein phenotype of certain mys alleles,
which is very similar to the venation phenotype of weak dei alleles
(Wilcox et al., 1989).
It is reasonable to assume that Dei regulates multiple target genes
in different cells and tissues. However, as for integrins, Dei regulates
speciﬁcally βPS integrin. We did not ﬁnd any evidence for regulation
of αPS1 or αPS2, which are expressed differentially in the two wing
layers, by Dei. Since βPS is the dimerization partner of both αPS1 and
αPS2, by regulating its expression Dei practically affects all integrin-
based adhesion processes at both the dorsal and ventral wing layers.
Our data also suggest that the effects of Dei on integrin-dependent
adhesion are not restricted to the wing. Ectopic expression of Dei led
to up-regulation of βPS expression in embryonic tissues, whereas loss
of Dei's activity caused a reduction in the level of βPS expression in the
cone cells of the eye.
In summary, we think of Dei as a general switch that turns on βPS
integrin expression wherever a sticky cell has to develop. Since such a
switch needs to be turned on in different tissues and different
developmental and physiological contexts, it is predicted that the dei
gene can respond to various signaling pathways and transcription
factors. Indeed, analysis of the regulatory region of the dei locus
demonstrated that it harbors multiple regulatory modules that
respond to different transcription factors working in different
developmental contexts (Nachman et al., unpublished data).
How transcription factors and signaling networks specify cell fates
is a central question in developmental biology. Although we have a
conceptual picture of how differential gene expression is used to
generate different types of cells, we still lack a full understanding on
how any cell is speciﬁed and how it acquires its unique properties. The
identiﬁcation of Dei as a mediator between signaling pathways that
specify intervein cell-fate and one of themost signiﬁcant realizators of
this fate, βPS integrin, adds to our understanding and ﬁts in a new
component into a genetic network that is, so far, roughly drawn.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2010.12.039.
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